BRIEF-Valeant comments on discount and rebate program for Nitropress and Isuprel
Sept 16 (Reuters) - Valeant Pharmaceuticals International Inc :
* Have negotiated contracts with many of purchasers to date
* "committed to working with hospital groups to ensure that purchasers of nitropress and isuprel have access to enhanced discount and rebate program"
* Valeant is "working diligently" to finalize remaining group purchasing organization Source text for Eikon: Further company coverage:
© Thomson Reuters 2017 All rights reserved.